NEO · MYCO.NE
Mydecine Innovations Group Inc.
CA$0.35CA$0.00 (0.0%)
Mydecine Innovations Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
CNQ · XCX.CN · CAD
Stock price, dividends, earnings
Quote as of Mar 25, 2026, 01:13 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Greenrise Global Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Greenrise Global Brands Inc.’s forward annual dividend is CA$1.07 per share, paid semi-annual. The forward yield is 21,333.2% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Greenrise Global Brands Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Greenrise Global Brands Inc., operating through its various subsidiaries, serves as a pharmaceutical distributor, providing medical cannabis products to pharmacies throughout Germany. The company also offers a broad selection of CBD-infused items, such as tinctures, sprays, oils, and skincare products, which are retailed in drugstores. Additionally, it is involved in the importation and sale of medical and cosmetic cannabis goods that meet stringent EU-GMP quality standards. The firm was formerly recognized as AMP Alternative Medical Products Inc. before officially changing its name to Greenrise Global Brands Inc. in November 2021. Its main corporate offices are located in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:51 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.35CA$0.00 (0.0%)
Mydecine Innovations Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.40CA$0.00 (0.0%)
Global Health Clinics Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
CA$0.22-CA$0.01 (-4.35%)
Captor Capital Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.28% below the high.
CA$0.63CA$0.00 (0.0%)
Vibe Growth Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.25% below the high.
CA$0.01CA$0.00 (0.0%)
Pharmadrug Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
CA$0.01-CA$0.01 (-50.0%)
Optimind Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.02+CA$0.01 (+50.0%)
Aquarius Surgical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
CA$0.10-CA$0.03 (-23.08%)
Vaxil Bio Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.52% below the high.
